首站-论文投稿智能助手
典型文献
Natural product 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose is a reversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase
文献摘要:
Aerobic glycolysis,also known as the Warburg effect,is a hallmark of cancer cell glucose metabolism and plays a crucial role in the activation of various types of immune cells.Glyceraldehyde 3-phosphate dehydrogenase(GAPDH)catalyzes the conversion of D-glyceraldehyde 3-phosphate to D-glycerate 1,3-bisphosphate in the 6th critical step in glycolysis.GAPDH exerts metabolic flux control during aerobic glycolysis and therefore is an attractive therapeutic target for cancer and autoimmune diseases.Recently,GAPDH inhibitors were reported to function through common suicide inactivation by covalent binding to the cysteine catalytic residue of GAPDH.Herein,by developing a high-throughput enzymatic screening assay,we discovered that the natural product 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose(PGG)is an inhibitor of GAPDH with Ki=0.5 μM.PGG blocks GAPDH activity by a reversible and NAD+and Pi competitive mechanism,suggesting that it represents a novel class of GAPDH inhibitors.In-depth hydrogen deuterium exchange mass spectrometry(HDX-MS)analysis revealed that PGG binds to a region that disrupts NAD+and inorganic phosphate binding,resulting in a distal conformational change at the GAPDH tetramer interface.In addition,structural modeling analysis indicated that PGG probably reversibly binds to the center pocket of GAPDH.Moreover,PGG inhibits LPS-stimulated macrophage activation by specific downregulation of GAPDH-dependent glucose consumption and lactate production.In summary,PGG represents a novel class of GAPDH inhibitors that probably reversibly binds to the center pocket of GAPDH.Our study sheds new light on factors for designing a more potent and specific inhibitor of GAPDH for future therapeutic applications.
文献关键词:
作者姓名:
Wen Li;Li-ping Liao;Ning Song;Yan-jun Liu;Yi-luan Ding;Yuan-yuan Zhang;Xiao-ru Zhou;Zhong-ya Sun;Sen-hao Xiao;Hong-bo Wang;Jing Lu;Nai-xia Zhang;Hua-liang Jiang;Kai-xian Chen;Chuan-peng Liu;Jie Zheng;Ke-hao Zhao;Cheng Luo
作者机构:
School of Pharmacy,Key Laboratory of Molecular Pharmacology and Drug Evaluation(Yantai University),Ministry of Education,Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong,Yantai University,Yantai 264005,China;Drug Discovery and Design Center,the Center for Chemical Biology,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Center of Immunological Diseases,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Gastroenterology,Xinhua Hospital,School of Medicine,Shanghai Jiaotong University,Shanghai 201210,China;Department of Analytical Chemistry,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;School of Life Science and Technology,Shanghai Tech University,Shanghai 201210,China;School of Life Science and Technology,Harbin Institute of Technology,Harbin 200092,China;Department of Pharmacology,College of Pharmacy,Fujian Medical University,Fuzhou 350108,China
引用格式:
[1]Wen Li;Li-ping Liao;Ning Song;Yan-jun Liu;Yi-luan Ding;Yuan-yuan Zhang;Xiao-ru Zhou;Zhong-ya Sun;Sen-hao Xiao;Hong-bo Wang;Jing Lu;Nai-xia Zhang;Hua-liang Jiang;Kai-xian Chen;Chuan-peng Liu;Jie Zheng;Ke-hao Zhao;Cheng Luo-.Natural product 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose is a reversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase)[J].中国药理学报(英文版),2022(02):470-482
A类:
Glyceraldehyde,glycerate,NAD+and
B类:
Natural,penta,galloyl,glucopyranose,reversible,glyceraldehyde,dehydrogenase,Aerobic,glycolysis,also,known,Warburg,effect,hallmark,cancer,glucose,metabolism,plays,crucial,role,various,types,cells,GAPDH,catalyzes,conversion,bisphosphate,6th,critical,step,exerts,metabolic,flux,control,during,aerobic,therefore,attractive,therapeutic,target,autoimmune,diseases,Recently,inhibitors,were,reported,function,common,suicide,inactivation,by,covalent,binding,cysteine,catalytic,residue,Herein,developing,high,throughput,enzymatic,screening,assay,discovered,that,natural,PGG,Ki,blocks,activity,Pi,competitive,mechanism,suggesting,represents,novel,class,In,depth,deuterium,exchange,mass,spectrometry,HDX,analysis,revealed,binds,region,disrupts,inorganic,resulting,distal,conformational,tetramer,interface,addition,structural,modeling,indicated,probably,reversibly,center,pocket,Moreover,inhibits,LPS,stimulated,macrophage,specific,downregulation,dependent,consumption,lactate,production,summary,Our,study,sheds,new,light,factors,designing,more,potent,future,applications
AB值:
0.552967
相似文献
Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
Yu Yu;Minzhen Tao;Libin Xu;Lei Cao;Baoyu Le;Na An;Jilin Dong;Yajie Xu;Baoxing Yang;Wei Li;Bing Liu;Qiong Wu;Yinying Lu;Zhen Xie;Xiaohua Lian-Department of Cell Biology,Basic Medical College,Army Medical University(Third Military Medical University),Chongqing 400038,China;MOE Key Laboratory of Bioinformatics and Bioinformatics Division,Center for Synthetic and System Biology,Department of Automation,Beijing National Research Center for Information Science and Technology,Tsinghua University,Beijing 100084,China;National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Department of Thoracic Surgery,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,Beijing 100730,China;Beijing Syngentech Co.,Ltd,Beijing 102206,China;School of Life Sciences,Tsinghua University,Beijing 100084,China;The Comprehensive Liver Cancer Center,The 5th Medical Center of PLA General Hospital,Beijing 100039,China
PGK1-coupled HSP90 stabilizes GSK3β expression to regulate the stemness of breast cancer stem cells
Wei Tang;Yu Wu;Xin Qi;Rilei Yu;Zhimin Lu;Ao Chen;Xinglong Fan;Jing Li-Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China;Department of Hepatobiliary and Pancreatic Surgery and Zhejiang Provincial Key Laboratory of Pancreatic Disease of the First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China;Department of Thoracic Surgery, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao 266003, China;Open Studio for Druggability Research of Marine Natural Products, Pilot National Laboratory for Marine Science and Technology (Qingdao), Qingdao 266003, China;Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Qingdao 266003, China
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
LIN28 coordinately promotes nucleolar/ribosomal functions and represses the 2C-like transcriptional program in pluripotent stem cells
Zhen Sun;Hua Yu;Jing Zhao;Tianyu Tan;Hongru Pan;Yuqing Zhu;Lang Chen;Cheng Zhang;Li Zhang;Anhua Lei;Yuyan Xu;Xianju Bi;Xin Huang;Bo Gao;Longfei Wang;Cristina Correia;Ming Chen;Qiming Sun;Yu Feng;Li Shen;Hao Wu;Jianlong Wang;Xiaohua Shen;George Q.Daley;Hu Li;Jin Zhang-Center for Stem Cell and Regenerative Medicine,Department of Basic Medical Sciences and the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310058,China;Department of Molecular Pharmacology & Experimental Therapeutics,Center for Individualized Medicine,Mayo Clinic,Rochester,MN,USA;Tsinghua-Peking Center for Life Sciences,School of Medicine,Tsinghua University,Beijing 100085,China;The Black Family Stem Cell Institute and Department of Cell,Developmental and Regenerative Biology,Icahn School of Medicine at Mount Sinai,New York,NY 10029,USA;Department of Biophysics and Department of Pathology of Sir Run Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou 310058,China;Department of Biological Chemistry and Molecular Pharmacology,Harvard Medical School,and Program in Cellular and Molecular Medicine,Boston Children's Hospital,Boston,MA,USA;Stem Cell Transplantation Program,Division of Pediatric Hematology Oncology,Boston Children's Hospital,Department of Biological Chemistry and Molecular Pharmacology,Harvard Medical School,Boston,MA,USA;College of Life Sciences,Zhejiang University,Hangzhou 310058,China;Department of Biochemistry,Zhejiang University School of Medicine,Hangzhou 310058,China;Institute of Life Science,Zhejiang University,Hangzhou 310058,China;Institute of Hematology,Zhejiang University,Hangzhou 310058,China;Zhejiang Laboratory for Systems and Precision Medicine,Zhejiang University Medical Center,Hangzhou 310058,China
Identification of sitagliptin binding proteins by affinity purification mass spectrometry
Xue-Ning Wang;Byu-Ri Sim;Hong Chen;Yun-Xiao Zheng;Jun-Biao Xue;Lei Wang;Wei-Sha Kong;Kuan Zhou;Shu-Juan Guo;Jing-Li Hou;Jiong Zhang;He-Wei Jiang;Sheng-Ce Tao-Shanghai Center for Systems Biomedicine,Key Laboratory of Systems Biomedicine(Ministry of Education),Shanghai Jiao Tong University,Shanghai 200240,China;State Key Laboratory of Microbial Metabolism,Joint International Research Laboratory of Metabolic and Developmental Sciences,MOE-LSB&MOE-LSC,School of Life Sciences and Biotechnology,Shanghai Jiao Tong University,Shanghai 200240,China;Instrumental Analysis Center,Shanghai Jiao Tong University,Shanghai 200240,China,41nflammation and Immune Mediated Diseases Laboratory of Anhui Province,School of Pharmacy,Anhui Medical University,Hefei 230032,China;Key Laboratory of Organofluorine Chemistry,Center for Excellence in Molecular Synthesis,Shanghai Institute of Organic Chemistry,University of the Chinese Academy of Sciences,Chinese Academy of Sciences,Shanghai 200032,China.
Screening of autoantibodies as biomarkers in the serum of renal cancer patients based on human proteome microarray
Yangyang Sun;Chengxi Liu;Huidong Zhong;Chenguang Wang;Haibo Xu;Wei Chen-Shenzhen Key Laboratory of Synthetic Genomics,Guangdong Provincial Key Laboratory of Synthetic Genomics,CAS Key Laboratory of Quantitative Engineering Biology,Shenzhen Institute of Synthetic Biology,Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences,Shenzhen 518055,China;Department of Urology,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,International Cancer Center,Shenzhen University School of Medicine,Shenzhen 518039,China;State Key Laboratory of Chemical Biology and Drug Discovery,Food Safety and Technology Research Centre and Department of Applied Biology and Chemical Technology,The Hong Kong Polytechnic University,Hong Kong 999077,China;Department of Medicinal Chemistry,Shantou University Medical College,Shantou 515041,China
Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
Yi Xiao;Ding Ma;Yun-Song Yang;Fan Yang;Jia-Han Ding;Yue Gong;Lin Jiang;Li-Ping Ge;Song-Yang Wu;Qiang Yu;Qing Zhang;Francois Bertucci;Qiuzhuang Sun;Xin Hu;Da-Qiang Li;Zhi-Ming Shao;Yi-Zhou Jiang-Key Laboratory of Breast Cancer in Shanghai,Department of Breast Surgery,Fudan University Shanghai Cancer Center;Department of Oncology,Shanghai Medical College,Fudan University,Shanghai,China;Human Phenome Institute,Fudan University,Shanghai,China;Department of Pathology,University of Texas Southwestern Medical Center,Dallas,TX,USA;Predictive Oncology team,Centre de Recherche en Cancérologie de Marseille(CRCM),INSERM UMR1068,CNRS UMR725,Aix-Marseille Université,Institut Paoli-Calmettes,Marseille,France;Department of Industrial Systems Engineering and Management,National University of Singapore,Singapore,Singapore
Targeting a cryptic allosteric site of SIRT6 with small-molecule inhibitors that inhibit the migration of pancreatic cancer cells
Qiufen Zhang;Yingyi Chen;Duan Ni;Zhimin Huang;Jiacheng Wei;Li Feng;Jun-Cheng Su;Yingqing Wei;Shaobo Ning;Xiuyan Yang;Mingzhu Zhao;Yuran Qiu;Kun Song;Zhengtian Yu;Jianrong Xu;Xinyi Li;Houwen Lin;Shaoyong Lu;Jian Zhang-State Key Laboratory of Oncogenes and Related Genes,Department of Pharmacy,Renji Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200127,China;Medicinal Chemistry and Bioinformatics Center Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Nutshell Therapeutics,Shanghai 201203,China;Academy of Integrative Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;School of Pharmaceutical Sciences,Zhengzhou University,Zhengzhou 450001,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19
Yang Yi;Meng Zhang;Heng Xue;Rong Yu;Yang-Oujie Bao;Yi Kuang;Yue Chai;Wen Ma;Jing Wang;Xiaomeng Shi;Wenzhe Li;Wei Hong;Junhua Li;Elishiba Muturi;Hongping Wei;Joachim Wlodarz;Szczepan Roszak;Xue Qiao;Hang Yang;Min Ye-State Key Laboratory of Natural and Biomimetic Drugs,School of Pharmaceutical Sciences,Peking University,Beijing 100191,China;CAS Key Laboratory of Special Pathogens and Biosafety,Center for Biosafety Mega-Science,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan 430071,China;University of Chinese Academy of Sciences,Beijing 100049,China;Faculty of Science and Technology,University of Silesia,Katowice 40-007,Poland;Department of Physical and Quantum Chemistry,Faculty of Chemistry,Wroclaw University of Science and Technology,Wroclaw 50-370,Poland
A potent PGK1 antagonist reveals PGK1 regulates the production of IL-1β and IL-6
Liping Liao;Wenzhen Dang;Tingting Lin;Jinghua Yu;Tonghai Liu;Wen Li;Senhao Xiao;Lei Feng;Jing Huang;Rong Fu;Jiacheng Li;Liping Liu;Mingchen Wang;Hongru Tao;Hualiang Jiang;Kaixian Chen;Xingxing Diao;Bing Zhou;Xiaoyan Shen;Cheng Luo-State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Department of Pharmacology&the Key Laboratory of Smart Drug Delivery,Ministry of Education,School of Pharmacy,Fudan University,Shanghai 201203,China;School of Pharmaceutical Science and Technology,Hangzhou Institute for Advanced Study,University of Chinese Academy of Sciences,Hangzhou 310024,China;School of Pharmaceutical Sciences,Zhejiang Chinese Medical University,Hangzhou 310053,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。